Sanara MedTech
SMTI
51 hedge funds and large institutions have $31.6M invested in Sanara MedTech in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 5 reducing their positions, and 2 closing their positions.
380% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 5
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
29% more capital invested
Capital invested by funds: $24.5M → $31.6M (+$7.13M)
16% more funds holding
Funds holding: 44 → 51 (+7)
1.64% more ownership
Funds ownership: 9.26% → 10.9% (+1.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$1.03M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$942K |
| 3 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$917K |
| 4 |
Renaissance Technologies
New York
|
+$726K |
| 5 |
Goldman Sachs
New York
|
+$418K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WIA
World Investment Advisors
Santa Barbara,
California
|
-$638K |
| 2 |
Lazard Asset Management
New York
|
-$258K |
| 3 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$221K |
| 4 |
SO
STRS Ohio
Columbus,
Ohio
|
-$48.4K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$13.5K |
SMTI Hedge Fund Activity: Q4 2024 in Review
51 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q4 2024, worth a combined $31.6M — up 29% from $24.5M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new SMTI positions and 2 closed out — a net gain of 7 holders — while 24 added to existing stakes and 5 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $1.03M. The largest seller was World Investment Advisors, exiting entirely with an estimated $638K sold.
- 51 institutional investors held Sanara MedTech (SMTI) as of Q4 2024, up from 44 in Q3 2024.
- Funds reported $31.6M of Sanara MedTech stock for Q4 2024, up 29% quarter-over-quarter.
- 9 funds opened new Sanara MedTech positions in Q4 2024 and 2 closed out, a net change of +7 holders.
- The largest Sanara MedTech buyer in Q4 2024 was Marshall Wace, an estimated $1.03M added.
- The largest Sanara MedTech seller in Q4 2024 was World Investment Advisors, an estimated $638K sold.
Based on aggregated 13F filings for Q4 2024.